fbpx
June 30, 2022

Irritable Bowel Syndrome Therapy Removed From Market (Again) Irritable Bowel Syndrome Therapy Removed From Market (Again)

Zelnorm (tegaserod), an oral short-term treatment of irritable bowel syndrome and constipation (IBS-C), is being removed from the US market effective June 30, according to the […]
June 29, 2022

CRC Screening Disparities Greatest Among Those Under 55 CRC Screening Disparities Greatest Among Those Under 55

Adults younger than 55 years were least likely to get screened for colorectal cancer over the past 2 decades, particularly if they were Hispanic or Asian […]
June 28, 2022

Baclofen Shows Limited Role in GERD Baclofen Shows Limited Role in GERD

A randomized clinical trial indicated that add-on baclofen may be of benefit to patients on adequate doses of proton pump inhibitors (PPI) with refractory gastroesophageal reflux […]
June 28, 2022

Novel Liver-Targeting Drug Offers Hope for AAT Deficiency Novel Liver-Targeting Drug Offers Hope for AAT Deficiency

LONDON — The novel liver-targeting agent fazirsiran has fared well in a small, but significant, study looking at its ability to improve liver histology in adults with […]
June 24, 2022

Pharmacologic Treatment of IBS: AGA Clinical Practice Guidelines Pharmacologic Treatment of IBS: AGA Clinical Practice Guidelines

The American Gastroenterological Association has issued new guidelines for the medical treatment of irritable bowel syndrome (IBS). The guidelines, which are separated into one publication for […]
June 24, 2022

Acute Hepatitis Cases in Children Show Declining Trend Acute Hepatitis Cases in Children Show Declining Trend

LONDON ― Case numbers of acute hepatitis in children show “a declining trajectory,” and COVID-19 and adenovirus remain the most likely, but as yet unproven, causative […]
June 22, 2022

Too Many of Our Plates Are Missing Immune-Boosting Microbes Too Many of Our Plates Are Missing Immune-Boosting Microbes

What we eat affects the trillions of bacteria, fungi, viruses, and other germs that live in our digestive tract and our diet shapes what scientists call […]
June 20, 2022

Impact of Eliminating Cost-Sharing on Follow-Up Colonoscopy Mixed Impact of Eliminating Cost-Sharing on Follow-Up Colonoscopy Mixed

Oregon and Kentucky recently enacted policies to eliminate financial disincentives that may have deterred people from undergoing a follow-up colonoscopy after a positive result on a […]
June 17, 2022

FDA Approves Risankizumab (Skyrizi) for Crohn’s Disease FDA Approves Risankizumab (Skyrizi) for Crohn’s Disease

The US Food and Drug Administration (FDA) has approved risankizumab-rzaa (Skyrizi, AbbVie) for a third indication — treatment of moderately to severely active Crohn’s disease in […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0